CompletedPhase 3NCT00003128

Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus

Studying Carcinosarcoma of the corpus uteri

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Gynecologic Oncology Group
Principal Investigator: Howard D. Homesley, MD
Gynecologic Oncology Network
Intervention: filgrastim(biological)
Enrollment: 166 enrolled
Eligibility: 18 years · FEMALE
Timeline: 1997

Study locations (17)

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
CCOP - Carle Cancer Center, Urbana, Illinois, United States
Indiana University Cancer Center, Indianapolis, Indiana, United States
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
CCOP - Ochsner, New Orleans, Louisiana, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Tufts - New England Medical Center, Boston, Massachusetts, United States
University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
Norris Cotton Cancer Center at Dartmouth Medical School, Lebanon, New Hampshire, United States
MBCCOP-Our Lady of Mercy Cancer Center, The Bronx, New York, United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
+2 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI) · Eastern Cooperative Oncology Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00003128 on ClinicalTrials.gov

Other trials for Carcinosarcoma of the corpus uteri

Additional recruiting or active studies for the same condition.

See all trials for Carcinosarcoma of the corpus uteri →

← Back to all trials